Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive disorder caused by mutation(s) in the TUBGCP6 gene, encoding gamma-tubulin complex component 6. It is characterized by microcephaly and chorioretinopathy.
Features include sometimes findings: Seizure and Nystagmus. 21 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 8 | Abnormality of retinal pigmentation, Retinal detachment, Retinal fold |
Brain and nerves |
TUBGCP6 function has not been fully characterized.
Microcephaly and chorioretinopathy 1 is caused by mutations in the TUBGCP6 gene on chromosome 22.
Genetic testing for TUBGCP6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for microcephaly and chorioretinopathy 1 has been reported in the published literature.
No clinical trials have been registered for microcephaly and chorioretinopathy 1.
212 publications have been identified in PubMed for microcephaly and chorioretinopathy 1. Kisho has analyzed 116 by research type. Research spans Basic Science / Preclinical (37%), Case Report / Case Series (26%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 43 | 37% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 7:42 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
4
Brain shrinkage (cerebral atrophy), Seizure, Global developmental delay |
Head and neck | 1 | Microcephaly |
Skin | 1 | Skin color changes (abnormality of skin pigmentation) |
Muscles | 1 | Brain shrinkage (cerebral atrophy) |
Growth and development | 1 | Short stature |
Patient case studies |
30 |
26% |
Research summaries | 24 | 21% |
Disease patterns and progression | 12 | 10% |
Other research | 2 | 2% |
Testing and diagnosis research | 2 | 2% |
Clinical study results | 2 | 2% |
New treatment approaches | 1 | 1% |
Sevagamoorthy A (2026). [PMID: 41671914](https://pubmed.ncbi.nlm.nih.gov/41671914/). *Mol Genet Metab*. [Clinical Trial Publication]
Yoo H (2026). [PMID: 41855203](https://pubmed.ncbi.nlm.nih.gov/41855203/). *Cell Rep*. [Basic Science / Preclinical]
Emreol HE (2026). [PMID: 41496005](https://pubmed.ncbi.nlm.nih.gov/41496005/). *Rheumatology (Oxford)*. [Case Report / Case Series]
Marinella G (2026). [PMID: 41871482](https://pubmed.ncbi.nlm.nih.gov/41871482/). *Mol Genet Metab*. [Epidemiology / Natural History]
Wingfield JL (2026). [PMID: 41844639](https://pubmed.ncbi.nlm.nih.gov/41844639/). *Nat Commun*. [Basic Science / Preclinical]
Singh A (2026). [PMID: 41242038](https://pubmed.ncbi.nlm.nih.gov/41242038/). *Bioorg Med Chem*. [Basic Science / Preclinical]
Alwalid O (2026). [PMID: 41839614](https://pubmed.ncbi.nlm.nih.gov/41839614/). *AJNR Am J Neuroradiol*. [Case Report / Case Series]
Wege L (2026). [PMID: 42064048](https://pubmed.ncbi.nlm.nih.gov/42064048/). *Front Immunol*. [Basic Science / Preclinical]
Batignes M (2026). [PMID: 41776196](https://pubmed.ncbi.nlm.nih.gov/41776196/). *Nat Commun*. [Basic Science / Preclinical]
Ogmen K (2026). [PMID: 41427784](https://pubmed.ncbi.nlm.nih.gov/41427784/). *JCI Insight*. [Basic Science / Preclinical]